Evidence map›Paper›PMID 29644437›Full record

ArticleBiomedical microdevices2018

A paperfluidic platform to detect Neisseria gonorrhoeae in clinical samples.

Audrey L Horst, Justin M Rosenbohm, Nikunja Kolluri, Justin Hardick, Charlotte A Gaydos, Mario Cabodi, Catherine M Klapperich, Jacqueline C Linnes

Abstract read
In one paragraph

Article in Biomedical microdevices, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. A Loop-Mediated Isothermal Amplification Assay for the Detection ofThe American journal of tropical medicine and hygiene · 2020
    Article
  17. Review
  18. Rapid electrostatic DNA enrichment for sensitive detection ofAnalytical methods : advancing methods and applications · 2020
    Article
  19. The Laboratory Diagnosis ofPathogens (Basel, Switzerland) · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Audrey L HorstDepartment of Biomedical Engineering, Boston University, Boston, MA, USA.
Justin M RosenbohmDepartment of Biomedical Engineering, Boston University, Boston, MA, USA.
Nikunja KolluriDepartment of Biomedical Engineering, Boston University, Boston, MA, USA.
Justin HardickSchool of Medicine, Johns Hopkins University, Baltimore, MD, USA.
Charlotte A GaydosSchool of Medicine, Johns Hopkins University, Baltimore, MD, USA.
Mario CabodiDepartment of Biomedical Engineering, Boston University, Boston, MA, USA.
Catherine M KlapperichDepartment of Biomedical Engineering, Boston University, Boston, MA, USA.
Jacqueline C LinnesWeldon School of Biomedical Engineering, Purdue University, West Lafayette, IN, USA. jlinnes@purdue.edu.
Boston University · USJohns Hopkins Medicine · USJohns Hopkins University · USPurdue University West Lafayette · US

Funding

TrainingU54EB007958 · NIBIB · JOHNS HOPKINS UNIVERSITY · PI Yukari C Manabe · 2007 to 2026
$34.6M
Rapid molecular diagnostic for chlamydia and gonorrhea at the point-of-careR01AI113927 · NIAID · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI KLAPPERICH, CATHERINE M. · 2015 to 2018
$1.4M
National Institute of Allergy and Infectious Diseases U54EB007958NIAID NIH HHS R01 AI113927NIBIB NIH HHS U54 EB007958NIBIB NIH HHS U54EB007958
6 · The paper itself

Abstract

Globally, the microbe Neisseria gonorrhoeae (NG) causes 106 million newly documented sexually transmitted infections each year. Once appropriately diagnosed, NG infections can be readily treated with antibiotics, but high-risk patients often do not return to the clinic for treatment if results are not provided at the point of care. A rapid, sensitive molecular diagnostic would help increase NG treatment and reduce the prevalence of this sexually transmitted disease. Here, we report on the design and development of a rapid, highly sensitive, paperfluidic device for point-of-care diagnosis of NG. The device integrates patient swab sample lysis, nucleic acid extraction, thermophilic helicase-dependent amplification (tHDA), an internal amplification control (NGIC), and visual lateral flow detection within an 80 min run time. Limits of NG detection for the NG/NGIC multiplex tHDA assay were determined within the device, and clinical performance was validated retroactively against qPCR-quantified patient samples in a proof-of-concept study. This paperfluidic diagnostic has a clinically relevant limit of detection of 500 NG cells per device with analytical sensitivity down to 10 NG cells per device. In triplicate testing of 40 total urethral and vaginal swab samples, the device had 95% overall sensitivity and 100% specificity, approaching current laboratory-based molecular NG diagnostics. This diagnostic platform could increase access to accurate NG diagnoses to those most in need.

Indexed as

Lab-On-A-Chip DevicesPaperPoint-of-Care TestingDNA, BacterialHumansNeisseria gonorrhoeaeDNA, Bacterialinternal amplification controlisothermal amplificationmolecular diagnosticNeisseria gonorrhoeaepaperfluidicpoint of carethermophilic helicase dependent amplificationurethral swabvaginal swab

Identifiers

PMID29644437
PMCPMC6154386
OpenAlexW2797344909

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.